Identification of Potential Plk1 Targets in a Cell-Cycle Specific
PD-1 blockade therapy promotes infiltration of tumor-attacking
Frontiers PD-1 Immune Checkpoint Blockade and PSGL-1 Inhibition
Shield1 ligand
Structural basis for blocking PD-1-mediated immune suppression by
Frontiers PD-1 Immune Checkpoint Blockade and PSGL-1 Inhibition
Anti-hPD1-Pem-hIgG1 Pembrolizumab Biosimilar Antibody
PD-1-CD28 fusion protein strengthens mesothelin-specific TRuC T
Shield1 ligand
PD-1 blockade therapy promotes infiltration of tumor-attacking
Side-Bi-Side Cells - PermeGear
Mechanistic dissection of the PD-L1:B7-1 co-inhibitory immune